Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cureveda

Cureveda
2010 FOUNDED
OOB STATUS
1-10 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Operator of a biotechnology company intended to develops therapies for the treatment of chronic diseases. The company's biotechnology services include developing small molecules targeting Nrf2 pathway for treatment of chronic obstructive pulmonary disease and other inflammatory disorders, enabling patients to counteract inflammation and cellular dysfunction caused due to oxidative stress.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1450 South Rolling Road
  • Halethorpe, MD 21227
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cureveda’s full profile, request a free trial.

Cureveda Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Sep-2016 00000 Completed Out of Business
2. Grant 07-Sep-2014 00000 00000 Completed Startup
1. Accelerator/Incubator $100K $100K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cureveda Executive Team (4)

Name Title Board
Seat
Contact
Info
Graham Allaway Ph.D Chief Executive Officer
Rajesh Thimmulappa Ph.D Co-Founder

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »

Cureveda Board Members (1)

Name Representing Role Since Contact
Info
Lode Debrabandere Ph.D Self Board Member 000 0000